HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

BVS

Bioventus Inc

Last Close
Dec 12 • 12:13PM ET
11.45
Dollar change
-0.13
Percentage change
-1.09 		%
Healthcare • Medical Devices • USA • NASD
Peers: ZBH SNN GMED IART XRAY OFIX BAX CNMD PODD MEDP
 | Held by: VTI IWM VXF AVUV DWAS IWN VTWO SCHA FESM IWO
Scroll to Statements
IndexRUT P/E- EPS (ttm)-0.62 Insider Own31.70% Shs Outstand65.34M Perf Week-1.60%
Market Cap929.54M Forward P/E18.14 EPS next Y0.63 Insider Trans0.21% Shs Float44.65M Perf Month-3.26%
Income-39.48M PEG- EPS next Q0.08 Inst Own49.01% Short Float2.70% Perf Quarter2.54%
Sales555.06M P/S1.67 EPS this Y1927.06% Inst Trans-3.33% Short Ratio2.73 Perf Half Y75.14%
Book/sh2.28 P/B5.03 EPS next Y55.78% ROA-5.00% Short Interest1.21M Perf Year136.16%
Cash/sh0.53 P/C21.58 EPS next 5Y- ROE-24.20% 52W Range3.90 - 14.38 Perf YTD117.34%
Dividend Est.- P/FCF33.35 EPS past 5Y-51.10% ROI-7.87% 52W High-20.35% Beta0.79
Dividend TTM- Quick Ratio0.99 Sales past 5Y10.81% Gross Margin65.56% 52W Low193.69% ATR (14)0.63
Dividend Ex-DateMar 26, 2004 Current Ratio1.41 EPS Y/Y TTM78.94% Oper. Margin4.51% RSI (14)46.38 Volatility5.07% 5.22%
Employees970 Debt/Eq2.65 Sales Y/Y TTM10.40% Profit Margin-7.11% Recom2.33 Target Price14.67
Option/ShortYes / Yes LT Debt/Eq2.37 EPS Q/Q36.40% Payout- Rel Volume0.28 Prev Close11.58
Sales Surprise4.30% EPS Surprise270.37% Sales Q/Q15.04% EarningsNov 05 BMO Avg Volume441.94K Price11.45
SMA20-1.35% SMA50-5.28% SMA20039.88% Trades Volume55,239 Change-1.09%
Date Action Analyst Rating Change Price Target Change
Dec-07-23Upgrade Canaccord Genuity Hold → Buy $7
Aug-09-23Upgrade Craig Hallum Hold → Buy $4 → $6
Nov-22-22Downgrade Craig Hallum Buy → Hold
Nov-09-22Downgrade JP Morgan Overweight → Underweight
Nov-09-22Downgrade Canaccord Genuity Buy → Hold $18 → $6
Mar-15-22Initiated Craig Hallum Buy $30
Nov-15-21Resumed Morgan Stanley Overweight $20
Nov-10-21Resumed JP Morgan Overweight $25
Jul-01-21Downgrade Goldman Buy → Neutral $20 → $19
Mar-08-21Initiated Morgan Stanley Overweight $18
Show Previous Ratings
Dec-06-24 09:55AM
Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet
(Zacks)
Nov-06-24 02:43AM
Q3 2024 Bioventus Inc Earnings Call
(Thomson Reuters StreetEvents)
02:14AM
Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...
(GuruFocus.com)
Nov-05-24 08:45AM
Bioventus (BVS) Matches Q3 Earnings Estimates
(Zacks) -16.27%
07:41AM
Bioventus: Q3 Earnings Snapshot
(Associated Press Finance)
07:30AM Loading…
07:30AM
Bioventus Reports Third Quarter Financial Results
(GlobeNewswire)
Nov-04-24 09:40AM
Are Medical Stocks Lagging Bioventus (BVS) This Year?
(Zacks)
07:09AM
Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For
(GuruFocus.com)
Oct-29-24 07:30AM
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
(GlobeNewswire)
Oct-15-24 04:01PM
Solventum Stock Earns 81 RS Rating
(Investor's Business Daily)
Oct-09-24 05:03PM
Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
(GuruFocus.com)
Oct-01-24 09:00AM
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
(GlobeNewswire)
Aug-29-24 07:09AM
Bull Of The Day: Bioventus (BVS)
(Zacks)
Aug-07-24 04:15PM
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
(GlobeNewswire) -7.79%
Aug-06-24 07:30AM
Bioventus Reports Second Quarter Financial Results
(GlobeNewswire) +29.23%
07:30AM Loading…
Jul-30-24 07:30AM
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
(GlobeNewswire)
Jun-05-24 10:17AM
Here's Why You Should Consider Buying Bioventus (BVS) Stock
(Zacks)
May-23-24 06:42AM
3 Stocks Under $10 With Mammoth Growth Prospects
(InvestorPlace)
May-09-24 07:29AM
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
(InvestorPlace) +8.33%
May-08-24 12:28PM
Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript
(Insider Monkey)
03:19AM
Bioventus Inc (BVS) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Significant ...
(GuruFocus.com)
May-07-24 11:41PM
Q1 2024 Bioventus Inc Earnings Call
(Thomson Reuters StreetEvents) +28.00%
07:00AM
Bioventus Reports First Quarter Financial Results
(GlobeNewswire)
Apr-29-24 07:30AM
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
(GlobeNewswire)
Mar-13-24 08:48AM
Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript
(Insider Monkey) -5.54%
Mar-12-24 10:20PM
Q4 2023 Bioventus Inc Earnings Call
(Thomson Reuters StreetEvents) +5.46%
09:11AM
Bioventus Inc (BVS) Reports Growth in Q4 Sales and Adjusted EBITDA, Provides Optimistic 2024 ...
(GuruFocus.com)
07:30AM
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
(GlobeNewswire)
Mar-04-24 08:00AM
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
(GlobeNewswire)
Jan-18-24 04:15PM
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
(GlobeNewswire)
04:15PM Loading…
Jan-12-24 04:15PM
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
(GlobeNewswire)
Dec-19-23 04:30PM
Bioventus Names Robert Claypoole as President and Chief Executive Officer
(GlobeNewswire)
Dec-06-23 08:00AM
Bioventus Agrees to Nationwide Contract with Aetna Medicare Advantage Plans for DUROLANE for Knee Osteoarthritis
(GlobeNewswire)
Nov-27-23 01:33AM
Smith & Nephew inks $180M CartiHeal buyout, capitalizing on Bioventus turmoil to land knee implant
(MedTech Dive)
Nov-12-23 09:02AM
Bioventus Inc. (NASDAQ:BVS) Q3 2023 Earnings Call Transcript
(Insider Monkey)
Nov-07-23 07:59AM
Bioventus Inc (BVS) Reports Q3 2023 Financial Results, Raises Full Year 2023 Financial Guidance
(GuruFocus.com)
07:00AM
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
(GlobeNewswire)
Oct-31-23 07:00AM
Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023
(GlobeNewswire) +5.37%
Oct-25-23 10:48AM
Bioventus (BVS) to Report Q3 Earnings: What's in the Cards?
(Zacks)
Sep-28-23 07:43AM
3 Value Medical Stocks to Buy for Safety Amid Market Volatility
(Zacks)
Sep-19-23 09:52PM
Bioventus to Present at the Cantor Global Healthcare Conference
(GlobeNewswire)
Sep-06-23 04:30PM
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
(GlobeNewswire)
Aug-16-23 09:02AM
Juniper Investment Company, LLC Increases Stake in Bioventus Inc
(GuruFocus.com) -5.26%
Aug-10-23 08:09AM
Bioventus works to trim debt under interim CEO
(American City Business Journals) +11.74%
Aug-08-23 10:02PM
Q2 2023 Bioventus Inc Earnings Call
(Thomson Reuters StreetEvents) +14.12% +5.41%
07:30AM
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
(GlobeNewswire)
Aug-04-23 08:30AM
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
(GlobeNewswire)
Aug-01-23 05:35PM
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
(GlobeNewswire)
Jun-23-23 06:35PM
Madrigal Pharmaceuticals and Bioventus Stock See Action From Activist Investors
(Barrons.com) -7.02%
May-25-23 06:38AM
Daily Vickers Top Buyers & Sellers for 05/25/2023
(Argus Research)
May-23-23 07:30AM
Bioventus Completes Divestiture of its Wound Business
(GlobeNewswire) +16.27%
May-18-23 12:07PM
Bioventus Inc. (NASDAQ:BVS) Q1 2023 Earnings Call Transcript
(Insider Monkey) +11.45%
May-17-23 08:33AM
Q1 2023 Bioventus Inc Earnings Call
(Thomson Reuters StreetEvents) +9.17%
May-16-23 04:15PM
Bioventus Reports First Quarter Financial Results
(GlobeNewswire)
May-15-23 05:33PM
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
(GlobeNewswire)
May-11-23 07:00AM
Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
(GlobeNewswire) +17.48%
May-10-23 09:00AM
Bioventus Announces Divestiture of its Wound Business
(GlobeNewswire) +6.95%
May-03-23 08:30AM
Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
(GlobeNewswire)
Apr-08-23 08:55AM
While institutions invested in Bioventus Inc. (NASDAQ:BVS) benefited from last week's 22% gain, private equity firms stood to gain the most
(Simply Wall St.)
Apr-05-23 10:52AM
Bioventus Inc. (NASDAQ:BVS) Q4 2022 Earnings Call Transcript
(Insider Monkey) +12.73%
08:00AM
Bioventus Announces CEO Leadership Change
(GlobeNewswire)
07:38AM
New Strong Sell Stocks for April 5th
(Zacks)
Mar-31-23 07:30AM
Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
(GlobeNewswire) -11.57%
07:00AM
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
(GlobeNewswire)
Mar-30-23 04:51AM
Heres Why Bioventus (BVS) Declined in Q4
(Insider Monkey)
Mar-29-23 08:55AM
Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023
(GlobeNewswire)
Mar-20-23 10:16AM
Are Options Traders Betting on a Big Move in Bioventus (BVS) Stock?
(Zacks)
Mar-16-23 08:30AM
Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023
(GlobeNewswire) -12.88%
Feb-28-23 07:30AM
Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition
(GlobeNewswire) +45.89%
Jan-27-23 02:49PM
Bioventus to divest assets ahead of major payments coming due
(American City Business Journals)
Jan-14-23 03:14PM
15 Largest Orthopedic Companies in the World
(Insider Monkey)
Jan-04-23 07:00AM
Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference
(GlobeNewswire)
Dec-27-22 02:53PM
2022 Year in Review: Layoffs hit Triangle biotech, pharma companies
(American City Business Journals)
Dec-09-22 11:58AM
Durham's Bioventus slashing headcount to rein in expenses
(American City Business Journals)
Nov-28-22 10:34PM
Why this Durham firm's stock is down more than 70% this month
(American City Business Journals) -20.41%
Nov-21-22 05:15PM
Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
(GlobeNewswire)
Nov-16-22 05:15PM
Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022
(GlobeNewswire) -9.45% -33.67%
Nov-10-22 05:38AM
Bioventus Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
(Simply Wall St.) +25.58%
Nov-09-22 06:18PM
Why Shares of Bioventus Fell 14% on Wednesday
(Motley Fool) -14.00%
Nov-08-22 07:30AM
Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
(GlobeNewswire) -57.51%
Oct-31-22 07:00AM
Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022
(GlobeNewswire)
Oct-12-22 08:00AM
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago
(GlobeNewswire)
Aug-30-22 08:00AM
Bioventus to Present at the Morgan Stanley Global Healthcare Conference
(GlobeNewswire)
Aug-12-22 02:32AM
Bioventus Inc. (BVS) Q2 2022 Earnings Call Transcript
(Motley Fool) +7.84%
Aug-11-22 07:00AM
Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance
(GlobeNewswire)
Aug-03-22 07:00AM
Bioventus Receives FDA 510(k) Clearance for SonaStar Elite
(GlobeNewswire)
Jul-26-22 07:00AM
Bioventus to Report Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022
(GlobeNewswire)
Jul-12-22 08:30AM
Bioventus Completes CartiHeal Acquisition
(GlobeNewswire) +9.67%
Jul-04-22 10:00AM
Investors one-year losses grow to 57% as the stock sheds US$66m this past week
(Simply Wall St.)
Jun-22-22 05:00AM
Durham firm reworks $450M acquisition amid stock market volatility
(American City Business Journals)
Jun-21-22 07:30AM
Bioventus Amends CartiHeal Acquisition Structure
(GlobeNewswire) -5.04%
Jun-15-22 08:33AM
Implied Volatility Surging for Bioventus (BVS) Stock Options
(Zacks)
May-10-22 01:00PM
Bioventus Inc. (BVS) Q1 2022 Earnings Call Transcript
(Motley Fool)
07:00AM
Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance
(GlobeNewswire)
May-04-22 02:54PM
With markets shaky, Durham firm scraps $415M plan to fund acquisition
(American City Business Journals) -10.41%
05:56AM
U.K. Companies Borrowing Costs Surge Past Covid-19 Pandemic Peak
(Bloomberg)
May-03-22 05:47PM
Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance
(GlobeNewswire)
01:57PM
Fearful Investors Should Buy Credit, Sell Stocks, JPMorgan Says
(Bloomberg)
May-02-22 07:00AM
Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis
(GlobeNewswire) -8.56%
Apr-26-22 02:59PM
Durham company needs to raise $415M for deal. Here's how it's doing it.
(American City Business Journals)
Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bartholdson John A.DirectorAug 16 '24Buy8.5580,000683,7366,913,857Aug 20 06:16 PM
Bartholdson John A.DirectorAug 19 '24Buy8.5525,500217,9666,939,357Aug 20 06:16 PM
Singleton Mark LeonardSVP & CFOJun 21 '24Sale5.579,21951,35084,895Jun 25 04:59 PM
D'Adamio AnthonySVP & General CounselJun 21 '24Sale5.575,90432,88595,576Jun 25 04:58 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerJun 21 '24Sale5.572,55914,25441,199Jun 25 04:58 PM
Singleton Mark LeonardSVP & CFOJun 20 '24Option Exercise0.0031,000094,114Jun 24 08:46 PM
D'Adamio AnthonySVP & General CounselJun 20 '24Option Exercise0.0019,8500101,480Jun 24 08:45 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerJun 20 '24Option Exercise0.008,600043,758Jun 24 08:45 PM
Singleton Mark LeonardSVP & CFOJun 17 '24Sale5.8413,75380,31863,114Jun 21 04:27 PM
D'Adamio AnthonySVP & General CounselJun 17 '24Sale5.8411,30866,03981,630Jun 21 04:25 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerJun 17 '24Sale5.848,75951,15335,158Jun 21 04:24 PM
McMurry-Heath MichelleDirectorJun 16 '24Option Exercise0.00386048,205Jun 18 05:44 PM
Ladone Mary KayDirectorJun 16 '24Option Exercise0.001,814052,488Jun 18 05:43 PM
Beyer PatDirectorJun 16 '24Option Exercise0.00965049,943Jun 18 05:43 PM
Singleton Mark LeonardSVP & CFOJun 15 '24Option Exercise0.0042,202076,867Jun 18 05:42 PM
D'Adamio AnthonySVP & General CounselJun 15 '24Option Exercise0.0034,696092,938Jun 18 05:40 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerJun 15 '24Option Exercise0.0026,875043,917Jun 18 05:40 PM
SUTTER MARTIN PDirectorJun 07 '24Option Exercise0.0030,400058,748Jun 11 08:47 PM
STALNECKER SUSAN MDirectorJun 07 '24Option Exercise0.0030,400079,464Jun 11 08:46 PM
NOHRA GUY PDirectorJun 07 '24Option Exercise0.0030,4000100,117Jun 11 08:46 PM
NEELS GUIDO JDirectorJun 07 '24Option Exercise0.0030,400058,748Jun 11 08:45 PM
HAWKINS WILLIAM ADirectorJun 07 '24Option Exercise0.0030,4000231,358Jun 11 08:45 PM
Ladone Mary KayDirectorJun 07 '24Option Exercise0.0030,400050,674Jun 11 08:44 PM
McMurry-Heath MichelleDirectorJun 07 '24Option Exercise0.0030,400047,819Jun 11 08:44 PM
Beyer PatDirectorJun 07 '24Option Exercise0.0030,400048,978Jun 11 08:43 PM
Bartholdson John A.DirectorJun 07 '24Option Exercise0.0030,400045,552Jun 11 08:43 PM
Bartholdson John A.DirectorJun 06 '24Option Exercise0.007,576015,152Jun 10 05:40 PM
Singleton Mark LeonardSVP & CFOApr 11 '24Sale4.754,00019,00034,665Apr 15 06:03 PM
D'Adamio AnthonySVP & General CounselApr 11 '24Sale4.753,05414,50658,242Apr 15 06:00 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerApr 11 '24Sale4.751,3256,29417,042Apr 15 05:58 PM
Singleton Mark LeonardSVP & CFOMar 22 '24Sale5.395,54129,85325,665Mar 25 05:36 PM
D'Adamio AnthonySVP & General CounselMar 15 '24Sale5.463,12517,06251,371Mar 20 06:41 PM
CHURCH KATRINA JSVP & Chief Compliance OfficerMar 15 '24Sale5.461,2176,64514,067Mar 20 06:41 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.